Apolipoprotein e gene polymorphism and its effect on plasma lipids in arteriosclerosis

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 10, 2013, Pages 2149-2152

  Zende, P D ^a   Bankar, M P ^b   Kamble, P S ^c   Momin, A A ^a  

^a Institute of medical sciences and research   (India)

^b B J Govt Medical College   (India)

^c SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITAL   (India)

Author keywords

Apolipoprotein e; Arteriosclerosis; Cerebrovascular stroke; Coronary artery disease; Hyperlipidemia; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE DISTRIBUTION; ALLELE; APO E2 GENE; APO E3 GENE; APO E4 GENE; ARTERIOSCLEROSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENDER; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84885192107     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/6195.3455     Document Type: Article

References (26)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367: 1747-57.
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937-52.
3. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008; 371(9624): 1612-23.
4. Scott J, Knott TJ, Shaw DJ, Brook JD. Localization of genes encoding Apolipoprotein CI, CII, and E to the p13->cen region of human chromosome 19. Hum Genet. 1985; 71: 144-46.
5. Rall SC, Weisgraber KH, Mahley RW. Human Apolipoprotein E: the complete amino acid sequence. J Biol Chem. 1982; 257: 4171-78.
6. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240: 622-30.
7. Ulrike B, Wilfried W, Gudrun I, Joachim H, Keith KS. The LDL- receptor- related protein LRP is an Apolipoprotein E binding protein. Nature. 1989; 341: 162-64.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8: 1-21.
9. Visvikis-Siest S, Marteau JB. Genetic variants pre disposing to cardiovascular disease. Curr Opin Lipidol. 2006; 17: 139-51.
10. Blackman JA, Worley G, Strittmatter WJ. Apolipoprotein E and brain injury: implications for children. Develop Med Child Neurol. 2005; 47: 64-70.
11. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, et al. Expression of human Apolipoprotein E3 or E4 in the brains of APO e-/- mice: isoform specific effects on neurodengeration. J Neurosci. 1999; 19: 4867-80.
12. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, Dyslipidemia and coronary heart disease. The Framingham offspring study. JAMA. 1994; 272: 1666-71.
13. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974: 20(4): 470-75.
14. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499-502.
15. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973; 19(5): 476-82.
16. SA Miller, DD Dykes, and HF Polesky. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.
17. Donohoe GG, Salomäki A, Lehtimäki T, Pulkki K, and Kairisto V. Rapid Identification of Apolipoprotein E Genotypes by Multiplex Amplification Refractory Mutation System PCR and Capillary Gel Electrophoresis. Clin Chem. 1999; 45(1): 143-46.
18. Wenham PR, Newton CR, Price WH. Analysis of Apolipoprotein E genotypes by the Amplification Refractory Mutation System. Clin Chem. 1991; 37: 241-44.
19. Newton CR, Kalsheker N, Graham A, Powell S, Gammack A, Riley J, et al. Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products. Nucleic Acids Res. 1988; 16: 8233-43.
20. Burman D, Mente A, Hegele RA, Islam S, Yusuf S, Anand SS. Relationship of the ApoE polymorphism to plasma lipid traits among South Asians, Chinese, and Europeans living in Canada. Atherosclerosis. 2009; 203: 192-200.
21. Singh PP, Singh M, Bhatnagar DP, Kaur TP, Gaur SK. Apolipoprotein E polymorphism and its relation to plasma lipids in coronary heart disease. Indian J Med Sci. 2008; 62: 105-12.
22. Singh PP, Singh M, Mastana SS. Apo E distribution in world populations with new data from India and the U.K. Ann Hum Biol. 2006; 33: 279-308.
23. Shajith A, Misra A, Meena K, Luthra K. Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases. Indian J Med Res. 2010; 132: 363-78.
24. Haddy N, De Bacquer D, Chemaly MM, Maurice M, Ehnholm C, Evans A et al. The importance of plasma Apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet. 2002; 10: 841-50.
25. Lehtinen S, Lehtimäki T, Sisto T, Salenius JP, Nikkilä M et al. Apolipoprotein E, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis. 1995; 114: 83-91.
26. Mendes-Lana A, Pena GG, Freitas SN, Lima AA, Nicolato RL, Nascimento-Neto RM, et al. Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto Study. Braz J Med Biol Res. 2007; 40: 49-56.